Intercontinental Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-653
Closed -$151K 161
2019
Q4
$151K Sell
653
-252
-28% -$55.5K 0.13% 132
2019
Q3
$175K Buy
905
+69
+8% +$13.2K 0.11% 135
2019
Q2
$154K Sell
836
-1
-0.1% -$179 0.08% 137
2019
Q1
$159K Hold
837
0.08% 141
2018
Q4
$163K Buy
+837
New +$163K 0.09% 133
2017
Q2
Sell
-1,235
Closed -$203K 127
2017
Q1
$203K Buy
+1,235
New +$205K 0.12% 134
2016
Q4
Sell
-1,293
Closed -$216K 139
2016
Q3
$216K Buy
+1,293
New +$219K 0.15% 112
2016
Q2
Sell
-1,423
Closed -$213K 123
2016
Q1
$213K Buy
+1,423
New +$211K 0.16% 115

Other funds holding AMGN

Intercontinental Wealth Advisors's AMGN Position: Q1 2020 in Review

Intercontinental Wealth Advisors sold out of Amgen (AMGN) in Q1 2020, closing a stake of 653 shares — an estimated $151K sold.

Intercontinental Wealth Advisors first reported a position in AMGN in Q1 2016 and held it in 8 quarters. The position peaked at $216K in Q3 2016. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Intercontinental Wealth Advisors reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 653 Amgen shares in Q1 2020, an estimated $151K.
  • Intercontinental Wealth Advisors first reported a position in Amgen in Q1 2016 and held it in 8 quarters.
  • Intercontinental Wealth Advisors's Amgen position peaked at $216K in Q3 2016.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Intercontinental Wealth Advisors's 13F filing for Q1 2020, filed 19 Jan 2021.